EGFR and lung carcinoma: Kinase inhibitors of EGFR are used in EGFR mutated lung cancer patients (Lynch et al., 2004), and EGFR targeting monoclonal antibodies are used in colorectal cancer patients in combination with chemotherapy (Eisterer and Prager, 2019).